LINC02497

Across TCGA pan-cancer cohorts, LINC02497 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC02497 data layer.

The strongest signal is observed in thymoma (THYM), where higher LINC02497 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02497 expression acts as an unfavorable survival marker, although some lineages such as CESC and LGG show a favorable association.

THYM, STAD, and CESC are the cancer types where LINC02497 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.807	0.985	<.001	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	33	view →
CESC	DFS	Tertile	IV	0.744	0.161	.017	30	view →
READ	DFS	Tertile	IV	0.514	0.619	<.001	27	view →
KIRC	DFS	Tertile	All	0.410	0.653	.037	24	view →
KIRP	OS	Tertile	III,IV	0.268	0.808	.012	18	view →
THCA	DFS	Tertile	IV	0.380	0.723	.008	18	view →
BRCA	DFS	Tertile	II,III,IV	0.898	0.945	.029	12	view →
SARC	DFS	Median	All	0.530	0.653	.011	12	view →
ACC	DFS	Tertile	All	0.204	0.658	.008	9	view →
LGG	OS	Median	All	0.515	0.351	.008	6	view →
LUSC	DFS	Tertile	II,III,IV	0.763	0.582	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC02497–THYM (OS)

Open the THYM breakdown →